197 related articles for article (PubMed ID: 24748170)
1. Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis.
Wutka A; Palagani V; Barat S; Chen X; El Khatib M; Götze J; Belahmer H; Zender S; Bozko P; Malek NP; Plentz RR
PLoS One; 2014; 9(4):e95605. PubMed ID: 24748170
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
[TBL] [Abstract][Full Text] [Related]
3. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR
PLoS One; 2013; 8(10):e77433. PubMed ID: 24204826
[TBL] [Abstract][Full Text] [Related]
4. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L
BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.
Kim Y; Kim MO; Shin JS; Park SH; Kim SB; Kim J; Park SC; Han CJ; Ryu JK; Yoon YB; Kim YT
Ann Surg Oncol; 2014 Aug; 21(8):2684-98. PubMed ID: 24682719
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.
El Khatib M; Kalnytska A; Palagani V; Kossatz U; Manns MP; Malek NP; Wilkens L; Plentz RR
Hepatology; 2013 Mar; 57(3):1035-45. PubMed ID: 23172661
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of biliary carcinogenesis and growth.
Wise C; Pilanthananond M; Perry BF; Alpini G; McNeal M; Glaser SS
World J Gastroenterol; 2008 May; 14(19):2986-9. PubMed ID: 18494047
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
[TBL] [Abstract][Full Text] [Related]
9. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.
Okabe H; Beppu T; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Jono H; Ueda M; Shinriki S; Ando Y; Baba H
Ann Surg Oncol; 2011 Apr; 18(4):1175-84. PubMed ID: 21042948
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma.
Bhuria V; Xing J; Scholta T; Bui KC; Nguyen MLT; Malek NP; Bozko P; Plentz RR
Exp Cell Res; 2019 Dec; 385(2):111671. PubMed ID: 31634481
[TBL] [Abstract][Full Text] [Related]
12. Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro.
Lieke T; Ramackers W; Bergmann S; Klempnauer J; Winkler M; Klose J
BMC Cancer; 2012 Oct; 12():466. PubMed ID: 23057720
[TBL] [Abstract][Full Text] [Related]
13. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma.
Ryu HS; Chung JH; Lee K; Shin E; Jing J; Choe G; Kim H; Xu X; Lee HE; Kim DG; Lee H; Jang JJ
Hum Pathol; 2012 Dec; 43(12):2360-70. PubMed ID: 23084587
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity.
Miller T; Yang F; Wise CE; Meng F; Priester S; Munshi MK; Guerrier M; Dostal DE; Glaser SS
Dig Liver Dis; 2011 May; 43(5):395-403. PubMed ID: 21334995
[TBL] [Abstract][Full Text] [Related]
16. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
Balsano C; Conti B; Arciello M
Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009
[No Abstract] [Full Text] [Related]
17. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.
Sirica AE
Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):44-54. PubMed ID: 22143274
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines.
Müller A; Barat S; Chen X; Bui KC; Bozko P; Malek NP; Plentz RR
Int J Oncol; 2016 May; 48(5):2025-34. PubMed ID: 26935541
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Kleinegger F; Hofer E; Wodlej C; Golob-Schwarzl N; Birkl-Toeglhofer AM; Stallinger A; Petzold J; Orlova A; Krassnig S; Reihs R; Niedrist T; Mangge H; Park YN; Thalhammer M; Aigelsreiter A; Lax S; Garbers C; Fickert P; Rose-John S; Moriggl R; Rinner B; Haybaeck J
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):308-321. PubMed ID: 30419338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
